ArticleNature communications2025

Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization.

Chih-Jia Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.